SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $57 | -72.9% | 12,250 | -73.1% | 0.00% | -80.0% |
| Q1 2023 | $210 | -99.9% | 45,540 | +105.2% | 0.01% | -16.7% |
| Q1 2022 | $182,000 | -59.6% | 22,189 | -26.7% | 0.01% | -78.6% |
| Q4 2021 | $450,000 | -30.2% | 30,262 | -11.4% | 0.06% | -34.9% |
| Q3 2021 | $645,000 | +53.9% | 34,152 | +51.5% | 0.09% | -39.0% |
| Q2 2021 | $419,000 | -59.8% | 22,550 | -50.8% | 0.14% | -57.7% |
| Q1 2021 | $1,042,000 | -25.3% | 45,790 | -28.7% | 0.33% | -16.3% |
| Q4 2020 | $1,395,000 | – | 64,250 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $34,466,000 | 16.86% |
| Samsara BioCapital, LLC | 1,675,579 | $31,652,000 | 4.97% |
| First Light Asset Management, LLC | 2,191,439 | $41,396,000 | 2.73% |
| FRAZIER MANAGEMENT LLC | 1,468,663 | $27,743,000 | 2.22% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,306,000 | 2.13% |
| Opaleye Management Inc. | 537,800 | $10,159,000 | 1.90% |
| Parkman Healthcare Partners LLC | 163,389 | $3,086,000 | 0.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,233,695 | $42,194,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,629,000 | 0.63% |
| BVF INC/IL | 826,825 | $15,619,000 | 0.61% |